Sbc Medical Group Holdings Incorporated Revenue per Employee (SBC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Sbc Medical Group Holdings Incorporated  (NASDAQ: SBC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Sbc Medical Group Holdings Incorporated's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 14.36% in the second quarter 2026, year on year to cumulative value of $174 million, Sbc Medical Group Holdings Incorporated's revenue per employee grew on a trailing twelve months basis to $ 201,290, this is below the company average.
Within the Healthcare sector Employees of 401 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 3064, from total ranking in previous quarter at 3563. Sbc Medical Group Holdings Incorporated has 863 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SBC Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 14.36 % -9.39 % -10.93 % -18.43 % -19 %
Sales per Employee (TTM) $ 201,290 194,132 199,214 204,839 215,995
SBC's Total Ranking # 3064 # 3563 # 3101 # 3028 # 2967
Seq. Revenue Change 16.16 % 7.03 % -7.15 % -0.93 % -7.97 %

SBC Company Profile >> Back to SBC Efficiency Comparisons >> Compare SBC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 22
Healthcare Sector # 402
Overall Market # 3064

Revenue per Employee Statistics
High Average Low
$ 257,820 $ 221,122 $ 194,132
(Sep 30 2024)   (Mar 31 2026)



Financial Statements
Sbc Medical Group Holdings Incorporated's Revenue MRQ $ 49 Millions Visit SBC's Income Statement
Sbc Medical Group Holdings Incorporated's Revenues TTM $ 174 Millions Visit SBC's aggregate revenue growth
What are SBC's Sales? Visit SBC's Sales by Segment




Other Ratios
Sbc Medical Group Holdings Incorporated's Income per Employee
Employees in Healthcare Facilities
Healthcare Facilities Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SBC's Revenue per Employee versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SBC's Competitors
Revenue per Employee for SBC's Suppliers
Revenue per Employee for SBC's Customers

You may also want to know
SBC's Sales Growth Rates SBC's Pe Price to earnings ratio SBC's Receivables Turnover Ratio SBC's Stock Quote
SBC's Net Income Growth Rates SBC's Ps Price to Sales ratio SBC's Sales per Employee SBC's Asset Turnover Ratio
SBC's Net Margin SBC's Pb Price to Book ratio SBC's Financial Strength Ratios SBC's Dividend Payout Ratio
Date modified: 2026-09-01T20:08:58+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Strata Critical Medical Inc   352,149.75 $ 211.642  Million 601 
Opus Genetics Inc   352,000.00 $ 9.856  Million 28 
Conmed Corporation  351,706.92 $ 1,371.657  Million 3,900 
Bio rad Laboratories Inc   347,516.78 $ 2,589.000  Million 7,450 
American Shared Hospital Services  347,241.38 $ 30.210  Million 87 
Foghorn Therapeutics Inc   346,594.34 $ 36.739  Million 106 
Coherus Oncology inc   346,503.40 $ 50.936  Million 147 
Irhythm Holdings Inc   344,042.50 $ 825.702  Million 2,400 
Maxcyte inc   341,219.78 $ 31.051  Million 91 
C4 Therapeutics Inc   336,913.46 $ 35.039  Million 104 
Omada Health Inc   336,730.35 $ 308.445  Million 916 
Cumberland Pharmaceuticals Inc   336,223.53 $ 31.269  Million 93 
Avita Medical Inc   334,650.44 $ 75.631  Million 226 
Sutro Biopharma Inc   333,591.24 $ 45.702  Million 137 
Iovance Biotherapeutics inc   333,301.54 $ 324.969  Million 975 
Gossamer Bio Inc   328,925.93 $ 53.286  Million 162 
Pacific Biosciences Of California Inc   328,484.54 $ 159.315  Million 485 
Exagen Inc   324,668.18 $ 71.427  Million 220 
Intelligent Bio Solutions Inc   324,244.23 $ 4.215  Million 13 
Quanterix Corporation  324,237.79 $ 152.716  Million 471 
Nutriband Inc   323,536.00 $ 1.618  Million 5 
Tactile Systems Technology Inc   322,577.35 $ 350.319  Million 1,086 
Ceribell Inc   311,327.22 $ 101.804  Million 327 
Bionano Genomics Inc   311,092.78 $ 30.176  Million 97 
Biodesix Inc   308,200.60 $ 102.939  Million 334 
West Pharmaceutical Services Inc   308,046.30 $ 3,326.900  Million 10,800 
Beam Therapeutics Inc   305,352.25 $ 156.035  Million 511 
Sensus Healthcare Inc   304,900.00 $ 18.294  Million 60 
Schrodinger Inc   304,747.06 $ 259.035  Million 850 
Infusystem Holdings Inc  303,033.83 $ 143.335  Million 473 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.